◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Fidelity US Value Research Enhanced UCITS ETF USD Acc (FUS1) ETF Overview

Name: Fidelity US Value Research Enhanced UCITS ETF USD Acc (FUS1) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-01

Fidelity US Value Research Enhanced UCITS ETF USD Acc (FUS1) is an exchange-traded fund managed by FIL Investment Management (Luxembourg) S.A., Ireland Branch. It manages roughly £3 million in assets.

Interactive chart & fund stats →

FUS1 Fund Statistics

Expense ratio	0.25%
Assets under management	£3 million
Fund family	FIL Investment Management (Luxembourg) S.A., Ireland Branch
Inception	2024-12-04

The live price chart, fund profile and news are in the interactive FUS1 viewer.

Other Companies in —

FTES · First Trust Europe Growth Strength UCITS ETF A EUR Acc — £3 million
KFOR · iShares UK Foreign Focus UCITS ETF GBP (Acc) — £3 million
SN5R · Global X Internet of Things UCITS ETF USD Acc — €3 million
SNSG · Global X Internet of Things UCITS ETF USD Acc — £3 million
FUSV · Fidelity US Value Research Enhanced UCITS ETF USD Acc — €3 million
BCFW · UBS Nuclear Economies UCITS ETF USD Acc — €2 million
CTBA · Invesco Markets II plc - Invesco S&P 500 CTB Net Zero Pathway ESG UCITS ETF Acc — €2 million
SCTP · Invesco Markets II plc - Invesco S&P 500 CTB Net Zero Pathway ESG UCITS ETF Acc — £2 million

← FURY All “F” companies FUSA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.